摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-tetradecyloxybezoic acid | 15872-47-6

中文名称
——
中文别名
——
英文名称
4-tetradecyloxybezoic acid
英文别名
4-Pentadecyloxy-benzoesaeure;4-Pentadecoxybenzoic acid
4-tetradecyloxybezoic acid化学式
CAS
15872-47-6
化学式
C22H36O3
mdl
——
分子量
348.526
InChiKey
DVJCIBNTENTQSV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    8.8
  • 重原子数:
    25
  • 可旋转键数:
    16
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.68
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-tetradecyloxybezoic acid草酰氯三乙胺 作用下, 以 二氯甲烷 为溶剂, 生成 4-(4-Pentadecyloxy-benzoylsulfanyl)-benzoic acid
    参考文献:
    名称:
    摘要:
    A new series of achiral banana-shaped compounds ("S-n'') has been synthesised and studied by the classical techniques (optical microscopy, differential scanning calorimetry, X-ray diffraction and electro-optic investigations). The short homologues (S-6,S-7) present an intercalated smectic B6 and a two-dimensional B1 phase. The intermediate S-8-S-10 compounds only form a B1 phase while the mesophase of long homologues (S-11-S-16) is identified as a switchable smectic B2 mesophase.
    DOI:
    10.1039/b103143k
点击查看最新优质反应信息

文献信息

  • Biaxial smectic A phase in homologous series of compounds composed of highly polar unsymmetrically substituted bent-core molecules
    作者:B. K. Sadashiva、R. Amaranatha Reddy、R. Pratibha、N. V. Madhusudana
    DOI:10.1039/b109546c
    日期:2002.3.21
    Several compounds belonging to three new series of five-ring banana-shaped esters, which are unsymmetrically substituted with respect to the central phenyl ring, have been synthesised. One of the arms of these bent-core molecules has been terminally substituted with a highly polar cyano group while the other end contains an alkoxy chain. The mesophases exhibited by these compounds have been characterised using a combination of optical polarising microscopy, differential scanning calorimetry and X-ray diffraction studies. These studies indicate that most of the compounds show two smectic A mesophases which have a partial bilayer ordering. Conoscopic experiments clearly reveal that the lower temperature smectic A phase is biaxial in nature. A structural model has been proposed for the lower temperature biaxial smectic A phase. It is argued that quartets of molecules, which are conducive to the formation of the biaxial phase, can form in the layers. The in-layer birefringence of the biaxial smectic A phase has also been measured as a function of temperature for one of the compounds.
    我们合成了属于三个新的五环香蕉形酯系列的几种化合物,这些化合物的中心苯基环被非对称取代。这些弯曲核心分子的一个臂末端被高极性氰基取代,而另一端则含有烷氧基链。通过结合使用光学偏振显微镜、差示扫描量热法和 X 射线衍射研究,对这些化合物的介相进行了表征。这些研究表明,大多数化合物显示出两种具有部分双层有序性的 A 介相。显微镜实验清楚地表明,温度较低的共晶 A 相具有双轴性质。为低温双轴共晶 A 相提出了一个结构模型。该模型认为,有利于形成双轴相的分子四元组可以在层中形成。还测量了其中一种化合物的双轴共晶 A 相的层内双折射随温度变化的情况。
  • COMPOUND FOR TREATING CARTILAGE DISORDERS
    申请人:ONO Pharmaceutical Co., Ltd.
    公开号:EP2740724A1
    公开(公告)日:2014-06-11
    The present invention provides a compound of which active form is represented by a formula (A). and which can be injected into a joint cavity which is an affected part of disorders and can be accumulated in the joint cavity to exert the pharmacological effect thereof in a sustained manner, for the purpose of ameliorating cartilage disorders without developing any side effect. A compound according to the present invention, which is represented by a formula (I): (wherein all of symbols are as defined in the description), is a compound that can achieve the above-mentioned purpose. This compound does not exhibit any side effect on the cardiovascular system even when the compound is administered in an effective amount for exhibiting a cartilage regeneration activity, and is therefore extremely useful as a safe and effective preventive and/or therapeutic agent for cartilage disorders. Since a suspension produced using this compound can be injected without requiring the incision of the affected part, it can reduce the burden on patients, and is extremely useful as a medicinal agent.
    本发明提供了一种化合物,其活性形式由式(A)表示,可注射到受疾病影响的关节腔内,并可在关节腔内蓄积,以持续发挥其药理作用,从而达到改善软骨疾病而不产生任何副作用的目的。根据本发明的一种化合物,由式(I)表示: (其中所有符号如描述中所定义)表示的化合物,可以达到上述目的。该化合物即使以有效量施用也不会对心血管系统产生任何副作用,从而显示出软骨再生活性,因此作为一种安全有效的软骨疾病预防和/或治疗剂极为有用。由于使用该化合物生产的混悬液无需切开患病部位即可注射,因此可以减轻患者的负担,作为一种药物非常有用。
  • The Synthesis, Mesomorphic Behaviour and the Uniaxial Nature of 1,2,4,5-Tetra-(4-Alkoxybenzoyloxy) Benzenes
    作者:W. D. J. Amilaprasadh Norbert、John W. Goodby、Michael Hird、Kenneth J. Toyne、J. Cliff Jones、Jay S. Patel
    DOI:10.1080/10587259508038707
    日期:1995.2
    A homologous series of 1,2,4,5-tetra-(4-alkoxybenzoyloxy)benzenes (2, R = C4H9, C6H13 to C16H33 and C18H37) has been synthesised. Optical microscopy revealed that the compounds with R = C4H9, C6H13 to C10H21 have a nematic phase, compounds with R = C11H23 to C14H29 have nematic and smectic C phases and compounds with R = C15H31, C16H33 and C18H37 have only a smectic C phase. The T-N-I values show an 'odd-even' alternation which is typical of calamitic systems. The refractive indices for aligned samples of compound 2h (R = C10H21) demonstrate that the nematic phase is uniaxial.
  • Cyclic peptide derivatives
    申请人:ELI LILLY AND COMPANY
    公开号:EP0095295B1
    公开(公告)日:1987-01-14
  • US4399067A
    申请人:——
    公开号:US4399067A
    公开(公告)日:1983-08-16
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐